Phase I open label study of Futibatinib Food Effects in Healthy Adult Volunteers
Latest Information Update: 26 Apr 2021
At a glance
- Drugs Futibatinib (Primary)
- Indications Breast cancer; Cholangiocarcinoma; Gastric cancer; Lymphoid leukaemia; Myeloid leukaemia; Solid tumours; Urogenital cancer
- Focus Adverse reactions; Pharmacokinetics
- 26 Apr 2021 New trial record
- 17 Mar 2021 Results presented at the 122nd Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics